Indian firms announce $20.5 billion investment in US
Indian firms announced a combined $20.5 billion investment in the U.S. at the SelectUSA Investment Summit 2026, with over $19.1 billion allocated to pharmaceuticals. Sun Pharmaceutical's planned $11.75 billion acquisition of Organon & Co. is a key highlight.
after close1 source ↓written by the desknot a recommendation
- in investments
- $20.5 billion
- allocated to pharmaceuticals
- $19.1 billion
- acquisition of Organon
- $11.75 billion
Indian industry leaders pledged $20.5 billion in investments across the U.S. at the SelectUSA Investment Summit 2026. Key sectors include pharmaceuticals, technology, and engineering, with $19.1 billion allocated to pharmaceuticals alone. This move is expected to create thousands of jobs and enhance domestic supply chains.
• Major investment from Sun Pharmaceutical Industries with $11.75 billion acquisition of Organon & Co.
• Investments span states like New Jersey, Texas, and California, focusing on manufacturing and research centers.
Not investment advice. For informational purposes only.